DeWitt Sheila 4

What Happened

• Sheila DeWitt, a director of Enveric Biosciences, was granted 18,518 restricted shares on 2026-06-01. The shares were reported at $0.00 per share (acquisition code A) — a restricted stock award rather than an open-market purchase or sale. The grant is compensation-linked and will vest according to the company plan and her award agreement.

Key Details

• Transaction date: 2026-06-01; Form 4 filed 2026-06-03 (timely filing).
• Grant details: 18,518 shares granted at $0.00 per share (award/acquisition).
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Footnote: F1 — shares are restricted stock under the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan and will vest per the Plan and the reporting person's restricted stock award agreement.
• No 10b5-1 plan, sale, tax-withholding, or exercise activity disclosed in this filing.

Context

• Restricted stock awards are typically part of director/executive compensation and vest over time; they are not an immediate market purchase and do not by themselves signal short-term trading intent. Purchases or sales by insiders can be more informative about sentiment, while grants are primarily a form of pay and retention.